Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | SLC1A3 | P43003 | 1/20 | 1.00 |
| ▸ | SLC1A2 | P43004 | 1/20 | 1.00 |
| ▸ | SLC1A1 | P43005 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ARG1 | P05089 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 1/20 | 0.37 |
| ▸ | GABRD | O14764 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8480461 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL1133665 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL12648650 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL8480462 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL2808482 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL2484170 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL542244 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL17743411 | 0.98 | CYP2D6 (0.95) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL21402235 | 0.98 | CYP2D6 (0.95) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL6652332 | 0.86 | CYP2D6 (0.75) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291301-B1 | NON-INVASIVE CANCER TREATMENT | SCIENTIA BIOTECH S L (ES) | 2025-01-15 | — | — | EP | disclosed |
| EP-4291301-A1 | NON-INVASIVE CANCER TREATMENT | Scientia Biotech S.L. (ES) | 2023-12-20 | — | — | EP | disclosed |
| EP-4277635-A1 | MODIFIED MIR-135, CONJUGATED FORM THEREOF, AND USES OF SAME | Yeda Research and Development Co. Ltd (IL) | 2023-11-22 | — | — | EP | disclosed |
| WO-2022171826-A1 | NON-INVASIVE CANCER TREATMENT | SCIENTIA BIOTECH S.L (ES) | 2022-08-18 | — | — | WO | disclosed |
| EP-4043071-A1 | NON-INVASIVE CANCER TREATMENT | Scientia Biotech S.L. (ES) | 2022-08-17 | — | — | EP | disclosed |
| WO-2022153322-A1 | MODIFIED MIR-135, CONJUGATED FORM THEREOF, AND USES OF SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-07-21 | — | — | WO | disclosed |
| EP-1397370-B1 | BETA-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING | SUNTORY HOLDINGS LTD (JP) | 2014-07-23 | — | — | EP | disclosed |
| CN-103816168-A | Application of acteoside in preparing medicine protecting cranial nerve cells damaged by ingestion and restraint of glutamate transporter | XINJIANG UYGUR AUTONOMOUS REGION INST OF TRADITIONAL UYGUR MEDICINE | 2014-05-28 | — | — | CN | disclosed |
| EP-2560687-A2 | COMPOSITIONS AND METHODS FOR SELECTIVE DELIVERY OF OLIGONUCLEOTIDE MOLECULES TO SPECIFIC NEURON TYPES | Nlife Therapeutics S.L. (ES) | 2013-02-27 | — | — | EP | disclosed |
| WO-2011131693-A2 | COMPOSITIONS AND METHODS FOR SELECTIVE DELIVERY OF OLIGONUCLEOTIDE MOLECULES TO SPECIFIC NEURON TYPES | NLIFE THERAPEUTICS, S.L. (ES) | 2011-10-27 | — | — | WO | disclosed |
| US-20040242652-A1 | Beta benzyloxyaspartate derivatives with amino group on benzene ring | SUNTORY HOLDINGS LTD. (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1397370-A1 | B-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING | SUNTORY LIMITED (JP) | 2004-03-17 | — | — | EP | disclosed |
| US-20030050224-A1 | Blocking glutamate function at an ionotropic glutamate receptor. e.g., N-methyl-D-aspartate receptor, the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptor and the kainate receptor; brain disorders; spinal chord | NEDERGAARD MAIKEN (US) | 2003-03-13 | — | — | US | disclosed |
| WO-2003000698-A1 | β-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING | SUNTORY LIMITED (JP) | 2003-01-03 | — | — | WO | disclosed |
| US-6090560-A | SCREENING A COMPOUND FOR BINDING TO EXCITATORY AMINO ACID TRANSPORTER IN CELLS BY TRANSFORMING HOST CELL WITH RECOMBINANT EXPRESSION CONSTRUCT EXPRESSING HUMAN TRANSPORTER AND ASSAYING TO DETERMINE BINDING | OREGON HEALTH SCIENCES UNIVERSITY (US) | 2000-07-18 | — | — | US | disclosed |
| US-6060307-A | Amino acid transporters and uses | OREGON HEALTH SCIENCES UNIVERSITY (US) | 2000-05-09 | — | — | US | disclosed |
| US-5942537-A | ADMINISTERING A L-TRANS PYRROLIDINE DERIVATIVE TO INHIBIT THE TRANSPORT OF L-GLUTAMATE OR L-ASPARTATE OR AN EXCITATORY AMINO ACID NEUROTRANSMITTER AWAY FROM A SYNAPSE COMPRISING CONTACTING SYNAPSE WITH PYRROLIDINE DERIVATIVE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-08-24 | — | — | US | disclosed |
| US-5912171-A | A NUCLEIC ACID WHICH CODES A MAMMALIAN EXCITATORY AMINO ACID GLUTAMATE TRANSPORTER PROTEIN; GENE THERAPY, DIAGNOSIS FOR HUNTINGTON'S/PARKISON'S/ALZHEIMER'S, DISEASES, EPILEPSY, ANOXIA AND ISCHEMIA | OREGON HEALTH SCIENCE UNIVERSITY (US) | 1999-06-15 | — | — | US | disclosed |
| EP-0497895-A1 | METHOD OF INHIBITING THE TRANSPORT OF L-GLUTAMATE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1992-08-12 | — | — | EP | disclosed |
| WO-1991006536-A1 | METHOD OF INHIBITING THE TRANSPORT OF L-GLUTAMATE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242652-A1 | Beta benzyloxyaspartate derivatives with amino group on benzene ring | SLC1A5, SLC1A1, SLC7A1 | CYP2D6 2267/4885CYP1A2 3852/4885ALOX15 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.